chr1-42943239-T-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_006516.4(SLC2A1):c.101A>G(p.Asn34Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N34I) has been classified as Pathogenic.
Frequency
Consequence
NM_006516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Encephalopathy due to GLUT1 deficiency Pathogenic:4
- -
- -
This variant was identified as de novo (maternity and paternity confirmed). -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense variant Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000662199 /PMID: 15622525). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 15622525, 16217704, 23340081, 28116237, 28961260). Different missense changes at the same codon (p.Asn34Asp, p.Asn34Ile, p.Asn34Lys, p.Asn34Tyr) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000016115, VCV000159921, VCV000666289 /PMID: 15132717, 20129935, 32901917, 34712575 /3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:2
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15622525, 30616884, 28961260, 29199027, 16217704, 28018440, 30895386, 28116237, 23340081, 32025761, 32712428, 24847886) -
GLUT1 deficiency syndrome 1, autosomal recessive Pathogenic:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 34 of the SLC2A1 protein (p.Asn34Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant GLUT1 deficiency (PMID: 15622525, 16217704, 23340081, 28116237, 28961260). In at least one individual the variant was observed to be de novo. This variant is also known as c.280A>G. ClinVar contains an entry for this variant (Variation ID: 662199). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC2A1 function. For these reasons, this variant has been classified as Pathogenic. -
Dystonia 9;C1837206:Hereditary cryohydrocytosis with reduced stomatin;C1842534:Childhood onset GLUT1 deficiency syndrome 2;C3553859:Epilepsy, idiopathic generalized, susceptibility to, 12;C4551966:Encephalopathy due to GLUT1 deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at